Netflix Stands Firm Against Wankhede’s Ban Request for Series

Post by : Mara Collins

The popular OTT platform, Netflix, has taken a strong stance against IRS officer Sameer Wankhede's request in the Delhi High Court to halt the streaming of its latest series, “The Ba*ds of Bollywood.”** Wankhede asserts that the show tarnishes his reputation, seeking its removal from all platforms. However, Netflix contends that the series is a satire and should not be regarded as defamatory.

During the hearing on Thursday, November 27, 2025, Netflix maintained that the content incorporates elements of humour, parody, and commentary on the Bollywood industry’s landscape. They argued that creative expression enjoys legal protections and cannot be suppressed merely because someone feels offended. The platform highlighted that Wankhede should not take a short comedic portrayal of about one and a half minutes too seriously, especially since he acknowledges it as satire.

Senior advocate Rajiv Nayar, representing Netflix, informed the court that proving defamation in such instances necessitates a high standard of evidence. He pointed out that Wankhede cannot pursue an immediate ban without substantiating malice, which can only be determined at a comprehensive trial. He elaborated that merely associating the series with Shah Rukh Khan’s son, Aryan Khan, does not provide sufficient grounds for a ban.

Nayar elaborated that the series aims to depict the “dark side of Bollywood” and its stark truths. He emphasized that the entire show employs satire, exaggeration, and parody to critique the film industry, rather than targeting any individual. Viewed in its entirety, each character serves as a symbolic representation rather than a factual indictment.

The court has scheduled the next hearing for December 2, when it will review Wankhede’s rejoinder. The judge has also requested that Wankhede submits written arguments before the upcoming date.

Additionally, Shah Rukh Khan’s production company, Red Chillies Entertainment, which is behind the series, has also rejected Wankhede’s petition. Red Chillies noted that the case should not have been filed in Delhi, as neither the officer nor the production company is based there. They contended that pursuing the case in Delhi amounts to “forum shopping,” implying the choice of court for convenience.

In their response, Red Chillies asserted that the series is crafted as satire and falls under the umbrella of legitimate artistic expression. It makes reference to common controversies in Bollywood, including nepotism, celebrity culture, paparazzi issues, relationship scandals, and the challenges faced by up-and-coming filmmakers. All these components are presented through humour and parody.

Wankhede, however, dismissed these arguments in his rejoinder, claiming that the “defamatory content” was spread to retaliate against him for handling the drugs case involving Aryan Khan in 2021. He argued that the series' writer and director aimed to personally attack and embarrass him. Wankhede has since filed for ₹2 crore in damages, which he wishes to donate to the Tata Memorial Cancer Hospital.

Earlier, on October 8, the court had issued notices to several parties, including Netflix, Red Chillies Entertainment, Google, Meta, X Corp, RPSG Lifestyle Media, and unnamed individuals (John Doe), asking for their responses regarding the defamation lawsuit.

Wankhede’s plea argues that the show crafts a negative portrayal of anti-drug agencies and undermines public confidence in law enforcement. He highlighted that a particular scene shows a character making an obscene gesture right after saying “Satyamev Jayate,” a phrase from the National Emblem. He alleges that this violates the Prevention of Insults to National Honour Act, which prohibits insulting national symbols.

The court will evaluate all submissions before determining whether the series can keep streaming or if any restrictions are necessary. This case has drawn considerable public attention due to its link to Bollywood, freedom of expression, and the earlier notable drugs investigation.

Nov. 28, 2025 3:43 p.m. 320

Global News Entertainment News